SEC filing: Carmell Therapeutics pulls in $3M in investment funding

04/17/2011 | MedCityNews.com

Carmell Therapeutics said in a regulatory filing that it has secured $3 million in a round of Series A financing led by Harbor Light Capital Partners. Carmell CEO Alan West said the company plans to use the proceeds to establish a manufacturing plant and gather data for a pilot clinical study. Carmell specializes in making medical devices made of blood plasma-based plastics used to treat tissue and bone injuries.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA